Pathogenetic substantiation of an integrated approach to topical therapy of atopic dermatitis



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article contains a description of the various groups of drugs for topical treatment of atopic dermatitis with an assessment of their effectiveness, as well as the influence on the mechanisms of the immune response.

Full Text

Restricted Access

About the authors

E S Fedenko

Institute of Immunology, Moscow

T M Filimonova

Institute of Immunology, Moscow

Email: tatfil-doc@yandex.ru

O G Elisyutina

Institute of Immunology, Moscow

O V Shtyrbul

Institute of Immunology, Moscow

D D Niyazov

Institute of Immunology, Moscow

References

  1. Российский национальный согласительный документ по атопическому дерматиту. Под ред. Р.М. Хаитова, А.А. Кубановой. Атопический дерматит: рекомендации для практических врачей. М., «Фармарус принт». 2002, 24 с.
  2. Candi E., Schmidt R., Melino G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 2006, v. 6 (4), p. 328-340.
  3. Martin C., Alienke J., Monsuur, Jos Poell et al. SPIN K gene family and celiac disease susceptibility. Immunogenetics. 2007, v. 59 (5), p. 349-357.
  4. Bieber Thomas. Mechanisms of Disease Atopic Dermatitis. N. Engl. J. Med. 2008, v. 358, p. 1483-1494.
  5. Галямова Ю.А., Чернышева М.П. Распространенность атопического дерматита среди детей Российской Федерации. Вопр. совр. педиатр. 2009, № 2, с. 122-123.
  6. Williams H., Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J. Allergy Clin. Immunol. 2006, v. 118, p. 209-213.
  7. Аллергология и иммунология. Клинические рекомендации для педиатров. Под ред. А.А. Баранова, Р.М. Хаитова. М., «Союз педиатров России», 2008.
  8. Ильина Н.И. Аллергопатология в различных регионах России. Автореферат диссертации д-ра мед. наук. М., 1996.
  9. Феденко Е.С. Кожные проявления аллергии: клинические аспекты и принципы лечения. Цитокины и воспаление. 2005, № 3, 35 с.
  10. Феденко Е. С. Системный подход в лечении атопического дерматита. Леч. врач. 2003, № 3, с. 16-22.
  11. Bouwstra J., Pilgram G. New aspect of the skin barrier organization. Skin. Pharmacol. Appl. Skin. Physiol. 2001, v. 12, p. 52-62.
  12. Imokawa G., Jin K. et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 1991, v. 96, p. 523-526.
  13. Cork M.J., Danby S.G. et al. Epidermal barrier Dysfunction in Atopic Dermatitis. J. Invest. Dermatol. 2009, v. 129, р. 1892-1908.
  14. Berardesca E., Barbareschi M., Veraldi S. et al. Evaluation of efficacy of skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis. 2001, v. 45 (5), p. 280-285.
  15. Kucharekova M., van De Kerhof P.C. Randomized comparison of an emolient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis. Contact. Derm. 2003, v. 48 (6), p. 293-299.
  16. Nakagawa H., Etoh T., Yokota Y. et al. Tacrolimus has anti-fungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis. Clin. Drug Invest. 1996, v. 12, p. 244-250.
  17. Ruzicka T., Assmann T. Tacrolimus: The drug for the turn of the millennium? Arch. Dermatol. 1999, v. 16, p. 574-580.
  18. Luger T., van Leent E.J., Graeber M., Hedgecock S. et al. An emerging safe and effective treatment for atopic eczema. Br. J. Dermatol. 2001, v. 144, p. 788—94.
  19. Fleischer A.B. Jr., Abramovits W., Breneman D., Jaracz E. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J. Dermatol. Treat. 2007, v. 18 (3), p. 151-157.
  20. Ashcroft D.M., Dimmock P., Garside R. et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ. 2005, v. 5 (330), p. 516.
  21. El_Batawy M.Y., Bosseila M.A.W., Mahsali H.M., Hafez V.S.G.A. Topical calcinurin inhibitors in atopic dermatitis: a systemic review and meta-analysis. J. Dermatol. Science. 2009, v. 54, p. 76-87.
  22. Gupta A.K., Adamiak A., Chow M. Tacrolimus. A review of its use for the management of dermatoses. JEADV. 2002, v. 16, p. 100-114.
  23. Assman T., Horney B., Ruzicka T. Topical tacrolimus for the treatment of inflammatory skin diseases. Expert Opin. Pharmacother. 2001, v. 2 (7), p. 1167-1175.
  24. Rustin M.H.A. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. British Journal of Dermatology. 2007, v. 157, p. 861-873.
  25. Kang S., Licky A., Pariser D. et al. Long-term safety and efficacy of tacrolimus ointment for treatment of atopic dermatitis in children. J. Am. Acad. Dermatol. 2001, v. 44, p. 47-57.
  26. Y. Jun et al. Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients. Ped. Derm. 2008, v. 25, p. 1.
  27. Reitamo S., Wollenberg A. et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch. Dermatol. 2000, v. 136. p. 999-1006.
  28. Wollenberg A., Reitamo S., Atzori F. et al. Proactive treatment of atopic dermatitis in adults with 0,1% tacrolimus ointment. Allergy. No. 63, р. 742-750.
  29. Флуер Ф.С., Кудрявцева А.В., Прохоров В.Я. и соавт. Влияние энтеротоксинов S. aureus и epidermidis на течение атопического дерматита у детей. Педиатрия. 2009, № 2, с. 105-111.
  30. Akids C.A., Akids M., Bieber T. et al. Diagnostics and treatment of atopic dermatitis in children and adults: Consensus EAACI/AAAAI/PRACTALL J. Allergy Clin. Immunology. 2006, v. 61, p. 969-987.
  31. Akdis C.A., Akdis M., Bieber T. et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J. Allergy. 2006, v. 61, р. 969-87.
  32. Cho S.H., Strickland I., Boguniewicz M., Leung D.Y. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin J. Allergy Clin. Immunol. 2001, v. 108, p. 269-274.
  33. Pasyk K., Laskownicka Z., Zemburowa K., Porebska A. Mykosen. The effectiveness of different pimaricin (natamycin) preparations in the local treatment of mycotic infections. Mykosen. 1976, v. 19 (7), p. 241-6.
  34. Хлебникова А.Н. Комбинированные препараты в терапии дерматозов у лиц пожилого возраста. Клин. дерматол. и венерол. 2007, № 2, с. 79-83.
  35. Перламутров Ю.Н., Ольховская К.Б. Наружная терапия хронического кандидоза крупных складок. Клин. дерматол. и венерол. 2007, № 4, с. 25-29.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies